PAR 13.7% 29.0¢ paradigm biopharmaceuticals limited..

Ann: Change of Chief Financial Officer, page-21

  1. 312 Posts.
    lightbulb Created with Sketch. 34
    Yes Denial that is concerning
    I understood some exercised options
    let's not also forget that PR sold shares to fund a home etc. Something around $4m
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.